{
    "eid": "2-s2.0-85007506771",
    "title": "Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors",
    "cover-date": "2016-12-01",
    "subject-areas": [
        {
            "$": "Geriatrics and Gerontology",
            "@code": "2717"
        },
        {
            "$": "Neurology",
            "@code": "2808"
        },
        {
            "$": "Neurology (clinical)",
            "@code": "2728"
        }
    ],
    "keywords": [
        "Apomorphine",
        "Getting out of bed",
        "Nocturnal akinesia",
        "Nocturnal hypokinesia",
        "Parkinson's disease",
        "Sensors"
    ],
    "authors": [
        "Roongroj Bhidayasiri"
    ],
    "citedby-count": 31,
    "ref-count": 40,
    "ref-list": [
        "How well do Parkinson's disease patients turn in bed? Quantitative analysis of nocturnal hypokinesia using multisite wearable inertial sensors",
        "Disordered axial movement in Parkinson's disease",
        "Nocturnal journey of body and mind in Parkinson's disease: The manifestations, risk factors and their relationship to daytime symptoms. Evidence from the NIGHT-PD study",
        "The impact of the nocturnal disabilities of Parkinson's disease on caregivers' burden: Implications for interventions",
        "The impact of nocturnal disturbances on daily quality of life in patients with Parkinson\u2019s disease",
        "Non-recognition of depression and other non-motor symptoms in Parkinson\u2019s disease",
        "Sudden death in Parkinson's disease: A retrospective autopsy study",
        "The relevance of dopaminergic level in nocturnal disability in Parkinson's disease: Implications of continuous dopaminergic stimulation at night to treat the symptoms",
        "Achieving 24-hour control of Parkinson's disease symptoms: Use of objective measures to improve nocturnal disability",
        "Mov. Disord.",
        "Sensor-based evaluation and treatment of nocturnal hypokinesia in Parkinson's disease: An evidence-based review",
        "Madopar HBS in Parkinson patients with nocturnal akinesia",
        "A comparison of Madopar CR and standard Madopar in the treatment of nocturnal and early-morning disability in Parkinson's disease",
        "Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease",
        "24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease",
        "Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome",
        "Subjectively impaired bed mobility in Parkinson disease affects sleep efficiency",
        "Capturing nighttime symptoms in Parkinson disease: Technical development and experimental verification of inertial sensors for nocturnal hypokinesia",
        "Axial parkinsonian symptoms can be improved: The role of levodopa and bilateral subthalamic stimulation",
        "Sleep disorders in Parkinson's Disease",
        "Systematic review of levodopa dose equivalency reporting in Parkinson's disease",
        "Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)",
        "Roll-over detection and sleep quality measurement using a wearable sensor",
        "Circadian variation in plasma dopamine levels in man",
        "Nocturnal subcutaneous apomorphine infusion for severe insomnia in Parkinson's disease [2]",
        "The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease",
        "Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease",
        "Dopamine receptor agonists and sleep disturbances in Parkinson's disease",
        "Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD",
        "Time course of tolerance to apomorphine in parkinsonism",
        "Apomorphine tolerance in Parkinson's disease: Lack of a dose effect",
        "The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease",
        "Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients",
        "Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson\u2019s disease",
        "Tolerance to apomorphine develops and reverses rapidly",
        "Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment",
        "Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: A real life study of non motor effect",
        "ROLE OF SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN VOIDING DYSFUNCTION",
        "Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Tokyo",
            "affilname": "Juntendo University",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "affilname": "King's College Hospital",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Pathum Thani",
            "affilname": "Thailand National Electronics and Computer Technology Center",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}